Research in the Kaeberlein Lab is focused on developing therapies for age-associated diseases by targeting the pathways that regulate aging.
|2016-07-19||Interview with Dr. Kaeberlien on DVM360. "Rapamycin: A real fountain of youth?"|
|2016-07-01||"Rapamycin in aging and disease: maximizing efficacy while minimizing side effects" published in Oncotarget.|
|2016-07-01||"New insights into cell non-autonomous mechanisms of the C. elegans hypoxic response" and "New functional and biophysical insights into the mitochondrial Rieske iron-sulfur protein from genetic suppressor analysis in C. elegans" published in Worm.|
|2016-06-24||Podcast with Dr. Kaeberlein on SmartDrugSmarts: "Rapamycin: The Real Deal Anti-Aging Pill?"|
|2016-06-07||Dr. Kaeberlein discusses aging research and the cancer 'moon shot' on The Takeaway.|
|2016-05-17||Kaeberlein Lab research featured on the front page of the New York Times.|